Related Experiment Video
Updated: May 14, 2026

Evaluating Therapeutic Interventions in the SHIP-deficient Mouse Model of Crohn Disease-like Ileitis and Fibrosis
Published on: October 14, 2025
When Behçet Mimics Crohn's disease: A Diagnostic Challenge.
Judith Heiss1, Drilon Haziri1, Matthias Kolleck1
1Jena University Hospital, Clinic for Internal Medicine IV, Gastroenterology, Hepatology, Infectiology, Thuringia, Germany, Jena.
Diagnosing Behçet's syndrome (BS) can be challenging, especially when symptoms overlap with inflammatory bowel diseases like ulcerative colitis (UC) and Crohn's disease (CD). This case shows how a patient's diagnosis evolved from UC to CD, and finally to BS, achieving remission with infliximab.
Area of Science:
- Gastroenterology
- Rheumatology
- Dermatology
Background:
- Ulcerative colitis (UC) and Crohn's disease (CD) are chronic inflammatory bowel diseases (IBD) with overlapping symptoms.
- Behçet's syndrome (BS) is a multisystemic vasculitis that can present with gastrointestinal, mucocutaneous, and other systemic manifestations.
- Distinguishing between IBD and BS can be diagnostically challenging due to similar clinical presentations.
Purpose of the Study:
- To report a challenging case of a patient initially diagnosed with ulcerative colitis (UC), later revised to Crohn's disease (CD), and finally diagnosed with Behçet's syndrome (BS).
- To highlight the diagnostic difficulties in differentiating BS from IBD.
- To illustrate the successful management of BS presenting with severe gastrointestinal symptoms.
Main Methods:
- Case report of a 21-year-old male of Syrian descent.
- Clinical evaluation including colonoscopy.
- Diagnostic revision based on evolving clinical manifestations.
- Treatment with prednisolone and infliximab.
Main Results:
- Initial diagnosis of UC was revised to CD based on colonoscopy findings (pancolitis sparing descending and sigmoid colon).
- Development of oral, genital, and inguinal ulcers, along with papulopustular lesions, led to a revised diagnosis of BS.
- Remission was achieved with a short course of prednisolone followed by infliximab therapy.
Conclusions:
- Behçet's syndrome can mimic inflammatory bowel diseases, posing significant diagnostic challenges.
- A high index of suspicion and careful evaluation of mucocutaneous and systemic symptoms are crucial for diagnosing BS.
- Infliximab can be an effective treatment for gastrointestinal manifestations of BS.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Bowel Disease IV: Clinical Manifestations
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Inflammatory Bowel Disease I: Introduction

